All In MedTech

Device Trial Radar · NCT00824109

Prospective, Multicenter Study of the Second Generation Antimicrobial Graft in the Abdominal Position

Multicenter Clinical Study Assessing the Performance and the Safety of the Second Generation Antimicrobial Graft in the Abdominal Position

Last checked: Nov 19, 2026Latest source record: Dec 3, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

60

Planned (sponsor's estimate)

Start

Jul 2008

Primary completion

Sep 2011

Study completion Sep 2011

Sponsor

Lead sponsor
Datascope Corp.Not on our public-company list
Sponsor type
Industry
First posted
Jan 16, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this prospective trial is to demonstrate the safety and performance of the Second Generation Anti-Microbial vascular graft in the treatment of aneurysmal and occlusive diseases of the abdominal aorta.

Conditions

  • Aneurysmal Disease of the Abdominal Aorta
  • Occlusive Disease of the Abdominal Aorta

Interventions

  • Second Generation Anti-Microbial bifurcated vascular graft (InterGard)Device

    treatment of patients with aorto-iliac occlusion,stenosis, or aneurysm

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Graft patency at three yearsTime frame: three years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • CHU La Miletrie, 350 av. Jacques Coeur

    86021 Poitiers, France · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.